Association between MR-proADM concentration and treatment intensity of antihypertensive agents in chronic kidney disease patients with insufficient blood pressure control
Abstract Response to antihypertensive drugs in patients with chronic kidney disease (CKD) has great interindividual variability. Adrenomedullin (ADM) is produced abundantly in hypertension, but clearance is very rapid. Mid-regional proADM (MR-proADM) produced from an ADM precursor is considered a su...
Enregistré dans:
Auteurs principaux: | Motoshi Iwao, Ryota Tanaka, Yosuke Suzuki, Takeshi Nakata, Kohei Aoki, Akihiro Fukuda, Naoya Fukunaga, Ryosuke Tatsuta, Keiko Ohno, Hirotaka Shibata, Hiroki Itoh |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/23a40a1458d841bbb79e367f4c2dbd8c |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
MR-proADM as prognostic factor of outcome in COVID-19 patients
par: Emanuela Sozio, et autres
Publié: (2021) -
Role of MR-proADM in the risk stratification of COVID-19 patients assessed at the triage of the Emergency Department
par: Marilena Minieri, et autres
Publié: (2021) -
Mid-Regional Proadrenomedullin (MR-proADM) and Microcirculation in Monitoring Organ Dysfunction of Critical Care Patients With Infection: A Prospective Observational Pilot Study
par: Roberta Domizi, et autres
Publié: (2021) -
A case of improvement of clozapine-induced low leukocyte counts by adenine, cepharanthin and ninjin-yoei-to in a patient with treatment-resistant schizophrenia
par: Shintaro Kamei, et autres
Publié: (2021) -
ADME-Space: a new tool for medicinal chemists to explore ADME properties
par: Giovanni Bocci, et autres
Publié: (2017)